NAEGIS PHARMACEUTICALS
Naegis Pharmaceuticals Inc. is a Canadian biopharmaceutical company developing novel, small molecules for the treatment of serious inflammatory diseases.Chronic inflammatory disease represents an enormous societal and economic burden, particularly in an aging population, impacting both quality and quantity of life. Naegis Pharmaceuticals Inc. is driven to discover new therapies that target underlying chronic inflammatory processes in disease. The Naegis research team seeks to design new drugs that offer safer and more effective treatment options for patients, focusing first on serious eye conditions that result in damage to the back of the eye, with a program directed towards blocking the synthesis of pro-inflammatory mediators in disease.
NAEGIS PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2009-02-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.naegispharma.com
Total Employee:
11+
Status:
Active
Contact:
604-235-1682
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SPF LetsEncrypt Euro Microsoft Exchange Online Office 365 Mail ReCAPTCHA
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Osprey Pharmaceuticals USA
Osprey Pharmaceuticals USA develops novel protein therapeutics for the treatment of inflammatory and immune diseases.
Investors List
entrepreneurship@UBC
entrepreneurship@UBC investment in Pre Seed Round - Naegis Pharmaceuticals
HATCH ventures
HATCH ventures investment in Pre Seed Round - Naegis Pharmaceuticals
Creative Destruction Lab (CDL)
Creative Destruction Lab (CDL) investment in Non Equity Assistance - Naegis Pharmaceuticals
Official Site Inspections
http://www.naegispharma.com
- Host name: 89.67.208.35.bc.googleusercontent.com
- IP address: 35.208.67.89
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Naegis Pharmaceuticals"
Naegis Pharmaceuticals Inc. | Seeing the future in the fight against ...
Apr 25, 2024 · Naegis Pharmaceuticals is an ophthalmology-focused biopharmaceutical company developing new oral and topical therapies, active in an under-exploited biological pathway, …See details»
Our Partners | Naegis Pharmaceuticals Inc.
Naegis is pleased to partner with Ora Inc., the world’s leading ophthalmic research organization, for the development of its lead compound for allergic eye diseases. Partnering: The …See details»
Our Team | Naegis Pharmaceuticals Inc.
Naegis is led by a team of experienced drug discovery and development scientists supported by an exceptional Board of Directors and Advisors who together have multiple years leadership experience in major ophthalmic …See details»
Naegis Pharmaceuticals - Crunchbase Company Profile & Funding
Naegis Pharmaceuticals is driven to discover new therapies that target underlying chronic inflammatory processes in eye diseases.See details»
Naegis Pharmaceuticals - Overview, News & Similar companies
View Naegis Pharmaceuticals (www.naegispharma.com) location in British Columbia, Canada , revenue, industry and description. Find related and similar companies as well as employees …See details»
Naegis Pharma - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Naegis Pharma of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
David Burgoyne Ph.D Profile: Contact Information & Network
Dr. David Burgoyne is the Founder and serves as Co-Chief Executive Officer, President & Board Member at Naegis. He has over 20 years of experience in the business of drug discovery and …See details»
Our Pipeline | Naegis Pharmaceuticals Inc.
Our pipeline development focuses on eye diseases for which leukotrienes are believed to play an important role in driving inflammation and damage. These include both front of the eye …See details»
Naegis Pharmaceuticals Inc. - VentureRadar
Website: https://www.naegispharma.com/ Develops treatments for inflammatory conditions, focusing on novel small molecules targeting pro-inflammatory mediators in ocular and …See details»
Naegis Pharma secures financing to advance retinal disease …
May 1, 2024 · Naegis Pharmaceuticals, Inc. has closed on its latest funding round to support the advancement of its lead investigational compound, N0651, currently in clinical development for …See details»
Naegis Pharma Funds Novel Eye Drug | OBN - Ophthalmology …
Apr 29, 2024 · Naegis Pharmaceuticals Inc., a life sciences company specializing in inflammation and ophthalmology, announced the successful closure of a financing round to advance its lead …See details»
Naegis Pharmaceuticals closes financing to advance new …
Apr 25, 2024 · Over the next 12 months, the funding will support advancement of a patented lead compound through to approval of a U.S. FDA investigational new drug (IND) application to …See details»
Naegis Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Naegis. Use the PitchBook Platform to explore the full profile.See details»
Our Science | Naegis Pharmaceuticals Inc.
Naegis designed and synthesized a novel class of small molecules that block both LTB4 and cysLT production. Among a number of lead candidates in its proprietary library, Naegis has …See details»
Naegis Pharmaceuticals Inc. - Creative Destruction Lab
Naegispharma.com Naegis Pharmaceuticals Inc. Naegis Pharmaceuticals is developing treatments for inflammatory conditions with a focus on the discovery and development of novel …See details»
Naegis Pharmaceuticals - Products, Competitors, Financials, …
Naegis Pharmaceuticals is an ophthalmology-focused biopharmaceutical company developing new therapies for inflammatory eye diseases. It specializes in creating oral and topical …See details»
VigiAccess
VigiAccess was launched by the World Health Organization (WHO) in 2015 to provide public access to information in VigiBase, the WHO global database of reported potential side effects …See details»
Naegis Pharmaceuticals Closes Financing to Advance New …
Vancouver, April 25th, 2024: Naegis Pharmaceuticals Inc. (“Naegis”) a life sciences company focused on inflammation and ophthalmology, today announced the closing of a financing.Over …See details»
Naegis Pharmaceuticals, Inc. (Naegis Pharmaceuticals, Inc.) - 药物 …
了解Naegis Pharmaceuticals, Inc. (Naegis Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的，疾病领域:内分泌与代谢疾病，免疫系统疾病，技术平台:小分子化药，药 …See details»
Latest News | Naegis Pharmaceuticals Inc.
Feb 29, 2024 · Naegis Pharmaceuticals Inc. (“Naegis”) a life sciences company focused on inflammation and ophthalmology, today announced the closing of a financing.See details»